Immunic AG | WebDisclosure

Basculer en Français

10655	Companies
226724	Keywords
155168	Articles
120031	Press releases

Home
Companies
Immunic AG

PRESS RELEASE

published on 02/20/2025 at 13:30, 1 year 4 months ago

Immunic’s Oral IMU-856 Demonstrated Dose-Dependent Increase of GLP-1 in Celiac Disease Patients and Corresponding Effects in Preclinical Testing
Immunic's Oral IMU-856 shows dose-dependent increase of GLP-1 in celiac disease patients, potential as oral weight management treatment. New data presented in webcast

Immunic GLP-1 IMU-856 Celiac Disease Weight Management
BRIEF

published on 02/04/2025 at 12:35, 1 year 4 months ago

Immunic Announces February Participation in Key Conferences

Biotechnology Investor Engagement Immunic Conferences IMU-856 Data IMU-838 Research
BRIEF

published on 02/04/2025 at 12:35, 1 year 4 months ago

Immunic annonce sa participation à des conférences clés en février

Biotechnologie Engagement Des Investisseurs Conférences Immuniques Données IMU-856 Recherche IMU-838
PRESS RELEASE

published on 02/04/2025 at 12:30, 1 year 4 months ago

Immunic to Participate in Investor and Scientific Conferences in February
Immunic, Inc. (Nasdaq: IMUX) to participate in investor and scientific conferences in February, presenting research on IMU-856, IMU-838, and gastrointestinal diseases

Investor Conferences Immunic Inc. Scientific Conferences IMU-856 IMU-838
BRIEF

published on 01/07/2025 at 12:35, 1 year 5 months ago

Immunic's 2024 Achievements and Future Prospects

Clinical Trials Multiple Sclerosis Vidofludimus Calcium 2024 Milestones Immunic AG
BRIEF

published on 01/07/2025 at 12:35, 1 year 5 months ago

Réalisations et perspectives d'avenir d'Immunic en 2024

Essais Cliniques Sclérose En Plaques Immunic SA Vidofludimus Calcique Étapes Clés De 2024
PRESS RELEASE

published on 01/07/2025 at 12:30, 1 year 5 months ago

Immunic Highlights 2024 Accomplishments and Upcoming Milestones
Immunic, Inc. highlights its 2024 accomplishments and upcoming milestones, including positive trial results for vidofludimus calcium in multiple sclerosis. Strengthened team and secured private placement for future growth

Multiple Sclerosis Immunic Vidofludimus Calcium 2024 Accomplishments Upcoming Milestones
BRIEF

published on 11/26/2024 at 12:35, 1 year 7 months ago

Immunic, Inc. Set to Participate in December Investor Conference

Investor Conference Immunic, Inc. Vidofludimus Calcium Piper Sandler Small Molecule Therapies
BRIEF

published on 11/26/2024 at 12:35, 1 year 7 months ago

Immunic, Inc. s'apprête à participer à la conférence des investisseurs de décembre

Immunic, Inc. Conférence Des Investisseurs Vidofludimus Calcique Piper Sandler Thérapies À Base De Petites Molécules
PRESS RELEASE

published on 11/26/2024 at 12:30, 1 year 7 months ago

Immunic, Inc. to Participate in Investor Conference in December
Immunic, Inc. to Participate in Investor Conference in December. Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing therapies for chronic inflammatory and autoimmune diseases, announces participation in Piper Sandler 36th Annual Healthcare Conference in New York

Investor Conference Biotechnology Immunic Inc. Clinical Pipeline Autoimmune Diseases

Accesswire

Published on 06/29/2026 at 13:45, 7 minutes ago

NuRAN Wireless Is Now SEC-Registered - 40-F Declared Effective, Nasdaq Listing One Step Closer
Published on 06/29/2026 at 13:30, 22 minutes ago

Lara Exploration Announces 14,000 Metre Validation Drilling Program Underway at the Planalto Project
Published on 06/29/2026 at 13:00, 52 minutes ago

Aclara Introduces Super Pure Rare Earth Carbonate ("SPREC")
Published on 06/29/2026 at 13:00, 52 minutes ago

Temas Resources Confirms Extensive High-Grade Mineralisation and Multiple Critical Mineral Credits at La Blache
Published on 06/29/2026 at 13:00, 52 minutes ago

Noram Lithium Engages Triforce Media Inc. to Support Corporate Communications Strategy

View all ACCESSWIRE

EQS Group

Published on 06/29/2026 at 13:37, 15 minutes ago

AI in satellite manufacturing: OHB Partners with Schwarz Digits
Published on 06/29/2026 at 13:20, 32 minutes ago

Embera Partners GmbH: A New Category for European Capital Market
Published on 06/29/2026 at 12:59, 52 minutes ago

Hanseatic Global Terminals plans to acquire 20% stake in Eurogate Container Terminal Hamburg
Published on 06/29/2026 at 12:55, 57 minutes ago

Halfords Group PLC: Director/PDMR Shareholding
Published on 06/29/2026 at 12:30, 1 hour 22 minutes ago

De la rivalité technologique à un « engagement constructif » entre l’Europe et la Chine : une nécessité à l’ère de l’IA

Les Echos

Published on 06/29/2026 at 10:56, 2 hours 56 minutes ago

GUILLEMOT CORPORATION S.A. | Déclaration hebdomadaire des transactions sur actions propres du 22 au 26 juin 2026
Published on 06/29/2026 at 10:56, 2 hours 56 minutes ago

GUILLEMOT CORPORATION S.A. | Weekly report share buyback from June 22 to June 26 2026
Published on 06/26/2026 at 17:45, 2 days 20 hours ago

Combined General Meeting, June 25, 2026
Published on 06/26/2026 at 17:45, 2 days 20 hours ago

Assemblée générale mixte du 25 juin 2026
Published on 06/26/2026 at 17:45, 2 days 20 hours ago

Descriptif du programme de rachat d'actions

View all LES ECHOS COMFI WIRE